Loading…
Smith & Nephew plc is projected to rise to $34.10 by 2027, a +11% move from its current price of $30.70. SNN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $30.20 | $30.69 | $31.19 | -0.03% |
| Jul 14 | $29.99 | $30.68 | $31.39 | -0.05% |
| Jul 15 | $29.83 | $30.68 | $31.54 | -0.08% |
| Jul 16 | $29.69 | $30.67 | $31.67 | -0.11% |
| Jul 17 | $29.57 | $30.66 | $31.78 | -0.13% |
| Jul 18 | $29.46 | $30.65 | $31.89 | -0.16% |
| Jul 19 | $29.36 | $30.64 | $31.98 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.36 | $30.64 | $31.98 | -0.19% |
| Week 2 | $28.79 | $30.58 | $32.49 | -0.38% |
| Week 3 | $28.35 | $30.53 | $32.87 | -0.57% |
| Week 4 | $27.98 | $30.47 | $33.18 | -0.75% |
| Week 5 | $27.64 | $30.41 | $33.46 | -0.94% |
| Week 6 | $27.34 | $30.35 | $33.70 | -1.13% |
| Week 7 | $27.06 | $30.30 | $33.92 | -1.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Smith & Nephew plc is a healthcare company that develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Smith & Nephew was founded in 1856 and is headquartered in Watford, the United Kingdom.
It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprising instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies, ear, nose, and throat solutions, and advanced wound care products along with regenerative medicine products and advanced wound devices.
It serves the healthcare providers.
Smith & Nephew plc (SNN) is a healthcare company with current price $30.08 and a market capitalization of $12.72B, ranking 794 by market cap. The stock trades in a healthcare sector context and carries a Neutral near-term price tone.
Current indicators show RSI(14) at 40, with SMA50 at $31.11 and SMA200 at $33.62, suggesting prices remain between near-term moving averages. The 30-day range spans $27.75 to $32.60, with a support level at $29.10 and a resistance at $31.32. Annualized volatility stands at 20%, underscoring modest price swings within the current pattern.
A major floor 9.9% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 19.7% above — clearing it would confirm fresh momentum.
Key SNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.42 | Buy | $30.35 | Buy |
| MA 10 | $30.02 | Buy | $30.20 | Buy |
| MA 20 | $30.10 | Buy | $30.17 | Buy |
| MA 50 | $30.23 | Buy | $30.59 | Buy |
| MA 100 | $31.95 | Sell | $31.43 | Sell |
| MA 200 | $33.09 | Sell | $31.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.35 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 96.74 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 3.68 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | 0.23 | Buy |
| Ultimate (7,14,28) | 68.56 | Neutral |
| Momentum (10) | 0.48 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 30.59 | Buy |
| ADX (14) | 10.00 | Neutral |
| ATR (14) | 0.42 | Info |
Near term, the picture remains NEUTRAL with RSI(14) at 40. The stock sits between its 50-day and 200-day moving averages, with the SMA50 at $31.11 and the SMA200 at $33.62.
In the next 30 days, traders will watch for price action around the support of $29.10 and resistance of $31.32, within a 30-day range of $27.75–$32.60.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $28.73 | $30.70 | $37.32 | 0% | Neutral | |
| $27.93 | $34.10 | $43.53 | +11% | Neutral | |
| $30.71 | $38.20 | $50.08 | +24% | Bullish | |
| $33.22 | $41.97 | $56.19 | +37% | Bullish | |
| $39.74 | $50.87 | $69.34 | +66% | Bullish | |
| $42.71 | $55.34 | $76.62 | +80% | Bullish | |
| $42.62 | $55.85 | $78.44 | +82% | Bullish | |
| $45.83 | $60.70 | $86.34 | +98% | Bullish | |
| $46.18 | $61.77 | $88.91 | +101% | Bullish | |
| $50.55 | $68.25 | $99.34 | +122% | Bullish | |
| $69.59 | $98.00 | $149.48 | +219% | Bullish | |
| $134.33 | $202.86 | $331.70 | +561% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $28.73 | $30.70 | $36.10 | +0.00% |
| August 2026 | $25.46 | $29.80 | $35.63 | -2.94% |
| September 2026 | $25.47 | $29.95 | $36.10 | +0.53% |
| October 2026 | $25.89 | $30.57 | $37.09 | +2.06% |
| November 2026 | $25.64 | $30.39 | $37.07 | -0.60% |
| December 2026 | $25.61 | $30.44 | $37.32 | +0.18% |
Click any year to see its month-by-month SNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Smith & Nephew plc's 2026 outlook centres on $30.70, within a $28.73 to $37.32 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNN could reach as high as $43.53, with a base case around $34.10 and support toward $27.93 — roughly +11% from $30.70. A consolidation phase looks the most probable path here.
Expect SNN to range from $30.71 to $50.08 through 2028. The $38.20 average target implies a +24% move from current prices. That is up +12% on the projected 2027 average. Momentum favours further upside here.
The SNN price prediction for 2029 points to an average of $41.97 (low $33.22, high $56.19) — a potential gain of +37% on today's $30.70. Buyers look set to stay in control over this stretch.
In 2030, SNN is projected to trade between $39.74 and $69.34, averaging $50.87 — a potential gain of +66% from today's $30.70. That is up +21% on the projected 2029 average. Momentum favours further upside here.
Smith & Nephew plc's 2031 outlook centres on $55.34, within a $42.71 to $76.62 range. That is up +9% on the projected 2030 average. That marks a +80% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SNN could reach as high as $78.44, with a base case around $55.85 and support toward $42.62 — roughly +82% from $30.70. Momentum favours further upside here.
Expect SNN to range from $45.83 to $86.34 through 2033. The $60.70 average target implies a +98% move from current prices. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNN price prediction for 2034 points to an average of $61.77 (low $46.18, high $88.91) — a potential gain of +101% on today's $30.70. Momentum favours further upside here.
In 2035, SNN is projected to trade between $50.55 and $99.34, averaging $68.25 — a potential gain of +122% from today's $30.70. That is up +10% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Smith & Nephew plc's 2040 outlook centres on $98.00, within a $69.59 to $149.48 range. That is up +44% on the projected 2035 average. That marks a +219% change versus current levels. Momentum favours further upside here.
By 2050, SNN could reach as high as $331.70, with a base case around $202.86 and support toward $134.33 — roughly +561% from $30.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNN today (≈ 32.57329 SNN) could be worth
$6,607.9
+$5,607.9 (+561%) by 2050 · US Dollar
Based on the average projected SNN price of $202.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNNwould be worth at today's price.
$1,000 invested in SNN on Jul 10, 2025 (≈ 32.185388 SNN) would be worth
$988.09
-$11.91 (-1.2%) today · 0.99× · US Dollar
Based on a SNN entry price of $31.07 vs. today's $30.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $30.25 | $1,014.88 | +1.5% |
| 1 month ago | $30.9 | $993.53 | -0.6% |
| 3 months ago | $33.48 | $916.97 | -8.3% |
| 6 months ago | $33.68 | $911.52 | -8.8% |
| 1 year ago | $31.07 | $988.09 | -1.2% |
| All time (5.0y) ago | $43.28 | $709.33 | -29.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNN forecast.
Our base-case forecast reaches $61.00 around 2034.
Implied market cap at $61.00: $25.71B
The multi-year forecast shows a bullish trajectory from 2026 onward. For 2026, the min/max/avg are $29.10, $30.08, and $37.59, with an ROI of 0 and a NEUTRAL sentiment. By 2027, the avg rises to $33.71 with a max of $43.11 and ROI of 12.1, keeping the sentiment NEUTRAL.
The forecast accelerates into 2028 with an avg of $37.17 and a max of $48.80 (ROI 23.6), and into 2029 with an avg of $42.21 and a max of $56.57 (ROI 40.3). By 2030, the avg is $50.59 and the max $69.02 (ROI 68.2) with a BULLISH sentiment, followed by continued strength through 2031–2050 (2031 avg $54.33; 2032 $55.57; 2033 $59.96; 2034 $60.93; 2035 $68.81; 2040 $95.35; 2050 $206.70). The corresponding max values rise to $75.30 (2031), $78.10 (2032), $85.35 (2033), $87.77 (2034), $100.21 (2035), $145.51 (2040), and $338.08 (2050).
ROI grows from 0 in 2026 to 68.2 by 2030, 217 by 2040, and 587.2 by 2050. Sentiment shifts from NEUTRAL in 2026–27 to BULLISH from 2028 onward, reflecting an optimistic long-term outlook. These are estimates, not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $39.49, avg $50.59, max $69.02; ROI 68.2; sentiment BULLISH.
The forecast shows rising averages and ROIs over time, with 2027 ROI 12.1 and 2030 ROI 68.2, and bullish sentiment from 2028 onward, though estimates are not guarantees.
Yes—the 2035 max forecast is $100.21, while the 2035 avg is $68.81.
Current price $30.08; market cap $12.72B; rank 794.
The 30-day range is $27.75–$32.60 with a support at $29.10 and a resistance at $31.32.
Smith & Nephew plc Community Discussion
0Share your Smith & Nephew plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.